AMEX : EV
$0.06 (0.28%)
| Source | Headline |
|---|---|
|
General Motors Reports Strong Q2 Results and Raises Full-Year Guidance
General Motors (GM) saw its stock rise by 4% following a robust Q2 performance that exceeded expectations and an upward revision of its full-year guidance. Inv gurufocus.com - 2026-07-21 11:14:00 |
|
Innate Pharma Announces Completion of Enrollment in Phase 1 Dose Escalation Study of IPH4502, a Novel Nectin-4 Exatecan Antibody-drug Conjugate (ADC)
Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company"), today announced the completion of enrollment in the dose e gurufocus.com - 2026-07-21 02:00:00 |
|
EV Company News For The Month Of June 2026
Global electric car sales in May 2026 are up 4% YoY to 26% share. China sales down ~6% to 63% share. Europe is up 28% to 32% share. USA down ~19% to ~7%. EV market news: EVs are already crimping gasoline demand in leading markets such as China. EU readies tariffs on Chinese plug-in hybrids, report. NSW to spend A$6.5B on e-buses. BloombergNEF: The global passenger electric vehicle fleet is forecast to grow from seekingalpha.com - 2026-07-02 03:20:20 |
|
Superlight Secures $21M to Transform Middle Mile Logistics with Purpose-Built, Electric Trucks that Leverage Aerospace Design and Software-Centric Digital Architecture
YATELEY, England & SEATTLE--(BUSINESS WIRE)--Superlight, a commercial electric vehicle (EV) manufacturer, today announced it has raised an oversubscribed $21 million Series A. The round was co-led by Engine Ventures and 2150, and brings the company's total funding raised to date to $33 million. Superlight will use the fresh capital to complete the buildout of its UK manufacturing facility, fulfill initial sales in the UK and EU, and provide federalized vehicles for customer testing and US marke. businesswire.com - 2026-06-22 10:00:00 |
|
ChargePoint to Participate in J.P. Morgan Natural Resources Conference
CAMPBELL, Calif.--(BUSINESS WIRE)--ChargePoint Holdings, Inc. (NYSE:CHPT) (“ChargePoint”), a global leader in electric vehicle (EV) charging solutions, today announced that members of its executive team will participate in a fireside chat at the upcoming J.P. Morgan Natural Resources Conference, taking place Tuesday, June 23, 2026 at 2:25 pm ET. A webcast of the event will be available at: https://jpmorgan.metameetings.net/events/naturalresources26/sessions/319234-chargepoint-holdings-inc/webca. businesswire.com - 2026-06-17 16:05:00 |
|
Orion (Nasdaq: OESX) to Participate in the iAccess Alpha Virtual Best Ideas Summer Investment Conference 2026 on June 23–24, 2026
MANITOWOC, Wis., June 11, 2026 (GLOBE NEWSWIRE) -- Orion Energy Systems, Inc. (NASDAQ: OESX) (Orion Lighting), a provider of energy-efficient LED lighting, electric vehicle (EV) charging stations and maintenance services solutions, today announced that its management will be participating in the iAccess Alpha Virtual Best Ideas Summer Investment Conference 2026, taking place June 23–24, 2026. globenewswire.com - 2026-06-11 08:28:00 |
|
US Foods® 2025 Sustainability Report Highlights Progress Across Products, People and Planet
US Foods Holding Corp. (NYSE: USFD) â one of America's leading foodservice distributors â announced today the release of the company's [url="]2025 Sustaina gurufocus.com - 2026-06-01 11:00:00 |
|
Sigenergy Unveils SigenAgent, the First All-Domain AI Agent for the Renewable Energy Industry
SHANGHAI, May 29, 2026 - (ACN Newswire) - Sigenergy today introduced SigenAgent, the energy industry's first all-domain AI agent, fundamentally changing how hou gurufocus.com - 2026-05-29 10:00:00 |
|
Sigenergy Unveils SigenAgent, the First All-Domain AI Agent for the Renewable Energy Industry
HONG KONG, May 29, 2026 - (ACN Newswire) - Sigenergy today introduced SigenAgent, the energy industry's first all-domain AI agent, fundamentally changing how ho gurufocus.com - 2026-05-29 07:00:00 |
|
IMFINZI® (durvalumab) approved in the US in first and only immunotherapy combination for patients with BCG-naïve, high-risk non-muscle-invasive bladder cancer
AstraZeneca's IMFINZIÂ (durvalumab) in combination with Bacillus Calmette-GuÃrin (BCG) induction and maintenance therapy has been approved in the US for the gurufocus.com - 2026-05-28 22:00:00 |
|
Nuvve Announces Postponement of First Quarter Ended March 31, 2026, Financial Update
Nuvve Holding Corp. (âNuvveâ) (Nasdaq:NVVE), a global leader in advanced energy storage, grid modernization solutions and vehicle-to-grid (V2G) technology, gurufocus.com - 2026-05-15 07:00:00 |
|
DUK Likely to Beat Q1 Earnings Estimates: How to Play the Stock?
Duke Energy heads into Q1 earnings with modest growth forecasts and positive ESP, as demand gains and grid investments support results despite rising costs. zacks.com - 2026-04-29 12:50:20 |
|
Intel Comeback Shows Need for Fair Valuation: ETFs in Focus
Intel's comeback highlights valuation risks. AI ETFs look pricey -- here are relatively lower P/E options investors can consider now. zacks.com - 2026-04-29 11:03:00 |
|
4 Best-Performing ETF Areas of Last Week
Cannabis, semis, crude & hydrogen ETFs led last week as AI momentum, policy boost and Middle East tensions shaped market trends. zacks.com - 2026-04-28 09:01:26 |